TrialClinical and translational science2022

Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study.

Michael Boettcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.